22.67
0.17 (0.76%)
| Previous Close | 22.50 |
| Open | 21.96 |
| Volume | 149,086 |
| Avg. Volume (3M) | 421,493 |
| Market Cap | 1,137,027,712 |
| Price / Earnings (TTM) | 119.32 |
| Price / Sales | 0.370 |
| Price / Book | 1.43 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | 1.55% |
| Operating Margin (TTM) | 3.55% |
| Diluted EPS (TTM) | 0.730 |
| Quarterly Revenue Growth (YOY) | 53.40% |
| Quarterly Earnings Growth (YOY) | -54.90% |
| Total Debt/Equity (MRQ) | 87.19% |
| Current Ratio (MRQ) | 1.70 |
| Operating Cash Flow (TTM) | 62.85 M |
| Levered Free Cash Flow (TTM) | -48.55 M |
| Return on Assets (TTM) | 3.97% |
| Return on Equity (TTM) | 8.10% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Astrana Health Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 4.5 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -4.0 |
| Average | 0.63 |
|
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company’s three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 22.08% |
| % Held by Institutions | 53.86% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Steelpeak Wealth, Llc | 30 Sep 2025 | 579,937 |
| Northcrest Asset Manangement, Llc | 30 Sep 2025 | 448,381 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 45.00 (BTIG, 98.50%) | Buy |
| Median | 36.00 (58.80%) | |
| Low | 26.00 (Barclays, 14.69%) | Hold |
| Average | 35.75 (57.70%) | |
| Total | 3 Buy, 1 Hold | |
| Avg. Price @ Call | 23.45 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Jefferies | 25 Nov 2025 | 37.00 (63.21%) | Buy | 23.22 |
| Barclays | 24 Nov 2025 | 26.00 (14.69%) | Hold | 22.60 |
| TD Cowen | 10 Nov 2025 | 35.00 (54.39%) | Buy | 22.43 |
| BTIG | 07 Nov 2025 | 45.00 (98.50%) | Buy | 25.54 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Nov 2025 | Announcement | Astrana Health, Inc. Reports Third Quarter 2025 Results |
| 15 Oct 2025 | Announcement | Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |